AVFM09040: Bard Covera Vascular Covered Stent, Flared 9mm x 40mm, 80cm

Sign in to add this product to your favorites!
| Price: | $2,000.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 01-2027 |
| Express: | Need it tomorrow? Order in next 14 hours 24 minutes and choose overnight shipping at checkout. |
Related Items
AVFM09060 - Size: 9.00mm $2,000.00 per box of 1 Bard Covera Vascular Covered Stent, Flared 9mm x 60mm, 80cm Exp: 01-2027 Units in stock: 1 box of 1 | Order Qty |
AVSM09060 - Size: 9.00mm $2,000.00 per box of 1 Bard Covera Vascular Covered Stent, Straight 9mm x 60mm, 80cm Exp: 09-2026 Units in stock: 1 box of 1 | Order Qty |
Additional Details
BD Bard Covera Vascular Covered Stent
- Helical design for radial strength and flexibility
- Thumbwheel delivery facilitates accurate placement control
- Atraumatic tip designed to facilitate smooth insertion and removal at the access site
AccessGUDID Info
- FDA Product Code: PFV
- FDA Product Code Name: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
- GMDN Term Code: 61856
- GMDN Term Name: Central/peripheral venous endovascular stent-graft
- GMDN Term Description: A non-bioabsorbable tubular device designed to be implanted in a central and/or peripheral vein (e.g., subclavian, brachiocephalic) to maintain vessel lumen patency, typically to treat stenosis in the outflow of an arteriovenous fistula (AVF) or graft used for haemodialysis; it is not intended for coronary or intracranial venous stenting. It is a mesh structure made of metal [e.g., nickel-titanium alloy] that is covered with a synthetic polymer [e.g., polytetrafluoroethylene (ePTFE)] membrane (endovascular graft), and contains an inner carbon coating to help prevent platelet adhesion. It is typically expanded in situ and disposable devices associated with implantation may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE